Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Family & Advocates
- Remove People with Alcohol Use or Abuse Problems as Audience
- Remove People with Substance Use or Abuse Problems as Audience
- Remove Legal Community
- Remove Grant Seekers & Grantees
- Remove Brochure
- Remove Guidelines or Manual
- Remove Substance Abuse
- Remove Alcohol Abuse
- Remove People with Substance Use or Abuse Problems as Population Group
- Remove People with Alcohol Use or Abuse Problems as Population Group
Main page content
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: September 2019
This brochure provides an overview of the Sequential Intercept Model (SIM). The SIM is a strategic planning tool that helps communities better understand the gaps and resources they have in helping those with mental illness or substance use disorders who are in the criminal justice system.